ライフサイエンスコーパス: translational research

1 disease, and an embracing of the concept of 'translational research'.

2 fear and anxiety, along with the promise of translational research.

3 ith animal models would be of great value in translational research.

4 as well as integration of clinical data into translational research.

5 atric diseases, emphasizing its interest for translational research.

6 ard tests jeopardizes accurate diagnosis and translational research.

7 trong potential to accelerate both basic and translational research.

8 n culture and open new avenues for basic and translational research.

9 ta2* nAChRs in various CNS disorders and for translational research.

10 se to treatment is expanding in clinical and translational research.

11 form for xenograft mouse models in basic and translational research.

12 testine and provides new tools for basic and translational research.

13 r differential diagnostics and to facilitate translational research.

14 ous human cells are widely used in basic and translational research.

15 animal models and human patients to improve translational research.

16 and their identification is fundamental for translational research.

17 geneity to enhance precision in clinical and translational research.

18 addressed with targeted epidemiological and translational research.

19 part of a collaborative effort to accelerate translational research.

20 rate, safety, patient-reported outcomes, and translational research.

21 rendering them useful as an animal model in translational research.

22 nd future applications of PSCs for basic and translational research.

23 therapy and is a promising target for future translational research.

24 and is an invaluable resource for improving translational research.

25 foundation for evolutionary, functional, and translational research.

26 in the human embryo and fetus is crucial for translational research.

27 ble and controllable hPSC culture routine in translational research.

28 tion in the context of increased emphasis on translational research.

29 program is necessary to ensure leadership in translational research.

30 ell lines to provide renewable resources for translational research.

31 amework for further clinical and preclinical translational research.

32 man pain processing is crucial for improving translational research.

33 ith drugs/compounds for drug repurposing and translational research.

34 low new insights and hypotheses in basic and translational research.

35 uires increased funding for basic as well as translational research.

36 ability may be a limiting factor for further translational research.

37 peutic interest is of prime significance for translational research.

38 erspective, and leadership to the process of translational research.

39 te early neuropathology and aging effects in translational research.

40 n broad applications for MM-401 in basic and translational research.

41 onse rate (RR), safety, quality of life, and translational research.

42 mechanisms of PNDM but have limitations for translational research.

43 as prerequisites to progress in this area of translational research.

44 cluded response rate, safety assessment, and translational research.

45 tion of DNAm signatures into diagnostics and translational research.

46 address these issues that are pertinent for translational research.

47 tudies are essential to provide traction for translational research.

48 optimization of coagulation and fibrinolysis translational research.

49 nment has become a lively successful area of translational research.

50 making the NPU-threat test an ideal tool for translational research.

51 support of hospital-based interdisciplinary translational research.

52 odifications with important implications for translational research.

53 d resilience frameworks that guide basic and translational research.

54 e clinical success are a key area of current translational research.

55 rich training to learn the joy and agony of translational research.

56 outcome and leads to actionable findings for translational research.

57 tor the success/reproducibility of basic and translational research.

58 University Irving Institute for Clinical and Translational Research.

59 rning, but also to play an important role in translational research.

60 adaptive genes are elucidated for downstream translational research.

61 heir target organ are valuable for basic and translational research.

62 for continued utilization and progression in translational research.

63 omplex microsamples are challenging tasks in translational research.

64 toxicology, drug design, risk assessment and translational research.

65 ve proven to be of great value for basic and translational research.

66 nsive priority list of molecular targets for translational research.

67 al of collecting tissue to support basic and translational research.

68 pecies differences are substantial and limit translational research.

69 model organism for biological discovery and translational research.

70 discipline into the prevailing paradigm for translational research.

71 otentially costly mistakes in both basic and translational research.

72 ltimately leading to more rigorous basic and translational research.

73 cessful career as a surgeon performing basic/translational research.

74 ecificity of both settings in the context of translational research.

75 ve a central and catalytic role in basic and translational research.

76 tentially powerful tool for pre-clinical and translational research.

77 significant implications for both basic and translational research.

78 focusing on recent advances in clinical and translational research.

79 including exposure to cutting-edge clinical/translational research, access to some of the best scien

80 to advance understanding of human diseases, translational research across rodents and humans on stre

81 for future regulatory review and strengthen translational research across the melanoma disease conti

82 , nontraditional partnerships, and basic and translational research activities is recommended.

83 ories both in terms of basic research and in translational research aimed at increasing plant perform

84 What is advocated instead is "translational" research aimed directly at treating disea

85 MART has a wide range of functionalities for translational research and a large user community, but i

86 Substantial progress in translational research and advances in scanner technolog

87 s" provide novel capsid sequences for use in translational research and clinical applications.

88 ves from nuclease degradation is crucial for translational research and clinical diagnostics.

89 ed knowledgebase developed to support cancer translational research and drug discovery.

90 used knowledgebase for the support of cancer translational research and drug discovery.

91 ograms that range from basic neuroscience to translational research and finally clinical research to

92 a dependable genomic diagnosis platform for translational research and for the clinical management o

93 d Public Health's Institute for Clinical and Translational Research and Health Innovation Program.

94 ay remains a central focus in both basic and translational research and is a key modulator of develop

95 addresses an important challenge in current translational research and justifies further development

96 us research clearly demonstrate insufficient translational research and limited investment in diagnos

97 This has hampered translational research and our ability to identify clini

98 d in the Irish Centre for Fetal and Neonatal Translational Research and partly supported by Science F

99 ent samples will greatly expand the range of translational research and personalized medicine by iden

100 occurred in the past 10 years, facilitating translational research and supporting the inclusion of c

101 lish disease models, and provide a basis for translational research and testing of novel therapeutics

102 g data, we propose future directions in both translational research and the design of therapeutic str

103 in sensitivity, it may have implications for translational research and the development and assessmen

104 o communicate advances that bridge basic and translational research and their implementation across t

105 gate these challenges, refine approaches for translational research and ultimately improve patient ca

106 cting evidence derived from clinical trials, translational research, and basic science demands that i

107 anisms of these disorders, through basic and translational research, and in targeting the receptors o

108 echnique is now widely employed in basic and translational research, and increasingly is also used pr

109 tions of DHS analysis both for basic and for translational research, and may provide critical informa

110 nvened of world experts in immunology, human translational research, and positron emission tomographi

111 cusing on the use of ontologies in basic and translational research, and we demonstrate how research

112 aming patient waveform data for clinical and translational research, and will advance the study and m

113 An interdisciplinary, bench to bedside translational research approach is crucial for the succe

114 d to be addressed by a multidisciplinary and translational research approach to develop novel therapi

115 n the nonhuman primate (NHP) is valuable for translational research approaches in humans.

116 Both basic and translational research are continuously evolving, but th

117 Advances in translational research are often driven by new technolog

118 Barriers to COVID-19 translational research are surmountable and necessary in

119 Data from continuing clinical and translational research are urgently needed to improve, a

120 immune system represent a promising tool for translational research as they may allow modeling and th

121 In particular, the terms basic research and translational research as used today in biomedicine seem

122 These limitations underpin the need for more translational research-based clinical trials in well-def

123 opDesalting and concentrating GELFrEEular in translational research because of the value of character

124 enormous benefit for both basic science and translational research because over 98% of the human gen

125 microbiome and disease are incompatible with translational research because they are insufficiently s

126 Translational research between human and non-human prima

127 tures are irreplaceable models for basic and translational research but their use can be limited due

128 next-generation sequence-variation data, and translational research, but a comparable resource has no

129 overy in developmental biology as well as in translational research, but whether organoids can truly

130 t in preclinical research tools for filarial translational research by developing Loa loa mouse infec

131 zure taxonomy will guide future modeling and translational research by identifying universal rules go

132 New advances in translational research can be expected to heighten the i

133 hts comprise the following sections: Basic & Translational Research, Cardiac Failure & Myocarditis, C

134 Part One includes the sections: Basic & Translational Research, Cardiac Failure, Cardiomyopathie

135 Part One included the sections: Basic & Translational Research, Cardiac Failure, Cardiomyopathie

136 hts comprise the following sections: Basic & Translational Research, Cardiac Failure, Cardiomyopathie

137 rrelated with distant recurrence in both the translational research cohort within the Arimidex, Tamox

138 hy, and how for establishing therapeutic and translational research collaborations between academic a

139 researchers within both discovery-based and translational research communities.

140 orts of investigators working throughout the translational research continuum from basic science to p

141 accelerating cancer epidemiology across the translational research continuum in the 21st century: em

142 a burden and the most time-consuming part of translational research data analysis.

143 Using Stanford Translational Research Database, we identified patients

144 e we offer a Perspective on how a productive translational research dialog between preclinical models

145 s and to describe the results of preclinical translational research directed toward urologic applicat

146 ve malignancy the focus of a large concerted translational research effort.

147 children with AVD and is to explore ongoing translational research efforts.

148 gress has been made in the implementation of translational research, even for more common disorders i

149 In translational research, evidence supports the role of WB

150 l, this receptor is an attractive target for translational research: existing drugs with established

151 e amounts of data across basic, clinical and translational research fields.

152 emphasize recent epidemiological, basic, and translational research findings for iCCA.

153 we review the most current basic science and translational research findings on several of the most c

154 in models other than rodents, especially for translational research for human cellular therapy.

155 acilitate the use of the laboratory mouse in translational research for human health and disease, hel

156 ich could be widely implemented in basic and translational research for KC diagnosis and therapy in t

157 e disease of the skin, has been the focus of translational research for over 30 years, and both melan

158 erventions-and T2 translational research, or translational research for public health.

159 irst, we emphasize the importance of reverse translational research for understanding chronic pain-th

160 We describe a translational research framework applicable to environme

161 Translational research frequently fails to replicate in

162 Baldrick's Pediatric Dream Team Translational Research Grant (SU2C-AACR-DT1113), RO1 CA1

163 National Ovarian Cancer Coalition Dream Team Translational Research Grant, and V Foundation Translati

164 A great wealth of preclinical and translational research has been and is currently being d

165 e, recent advances in the field of basic and translational research have enhanced our understanding o

166 y, radiation oncology, radiology, pathology, translational research, health economics and patient adv

167 ocol for analysis of a common sample type in translational research: human peripheral blood mononucle

168 In the era of targeted therapy for cancer, translational research identifying molecular targets in

169 al metabolites with emphasis on clinical and translational research implications.

170 e exposed, suggesting that our findings have translational research implications.

171 t transformation and potentially facilitates translational research in a monocot model plant.

172 bstacles that need to be overcome to advance translational research in and tumor heterogeneity.

173 opted to accelerate scientific discovery and translational research in bio-nano science.

174 tween 2007 and 2009 and were enrolled in the Translational Research in Biomarker Endpoints in AKI coh

175 EPSCs present a unique cellular platform for translational research in biotechnology and regenerative

176 models have substantial utility in basic and translational research in cancer biology; however, study

177 o experiments, genetic analysis and clinical-translational research in cardiac neonatal lupus reveal

178 urred during a watershed period of basic and translational research in glycation that encompassed new

179 tabolic phenotyping is an expanding field of translational research in medicine, focusing on the iden

180 scuss gaps and opportunities in clinical and translational research in metastatic breast cancer.

181 sed, open-label phase 3 KRISTINE trial in 68 Translational Research In Oncology centres (hospitals an

182 nited States oncology centers throughout the Translational Research in Oncology network.

183 egorizations of HER2 by FISH status in BCIRG/Translational Research in Oncology trials.

184 nical, genomic, pharmacogenomic and advanced translational research in ophthalmology and vision scien

185 hat neuroeconomics is a potential bridge for translational research in psychiatry for several reasons

186 suitable genetic model has impaired further translational research in the field.

187 ering strategies, increasing the options for translational research in the vector control field.

188 ore likely to promote translational and post-translational research in tomato and additional species,

189 ignificant power in International Genetics & Translational Research in Transplantation Network to det

190 e and design of the International Genetics & Translational Research in Transplantation Network.

191 Translational research in trials combining Vitamin D and

192 of basic cancer biology and the promotion of translational research, including drug discovery and dru

193 d cell adhesion and migration as well as for translational research, including targeted intervention

194 Translational research informed by clinical observations

195 ity is increasing on an international scale, translational research initiatives are urgently needed t

196 The study was conducted at the Translational Research Institute for Metabolism and Diab

197 I (N = 15,301; 1971-1975), and the Stanford Translational Research Integrated Database Environment (

198 8 medium that serves as a tool for basic and translational research into human pluripotent stem cells

199 brain function and improve our capacity for translational research into neurological disorders.

200 ccessibility in humans have slowed basic and translational research into renal development and diseas

201 or the acceleration of human stem cell-based translational research into the causes and potential tre

202 The Translational Research Investigating Biomarker Endpoints

203 Using samples from the Translational Research Investigating Biomarker Endpoints

204 I from 24 US centers into the TRIUMPH study (Translational Research Investigating Underlying Disparit

205 I patients from 24 hospitals enrolled in the Translational Research Investigating Underlying disparit

206 treated at 24 hospitals participating in the Translational Research Investigating Underlying Disparit

207 The TRIUMPH (Translational Research Investigating Underlying Disparit

208 Data from the 24-center TRIUMPH (Translational Research Investigating Underlying Disparit

209 TRIUMPH (Translational Research Investigating Underlying Disparit

210 The TRIUMPH study (Translational Research Investigating Underlying Disparit

211 reproductive tract interaction that warrant translational research investigation.

212 s and has wider interest for fundamental and translational research involving exosomes.

213 Translational research involving genomics, microRNA, pro

214 e of autism as a diagnostic category guiding translational research is fraught with so many problems

215 Translational research is key to bridging the gaps betwe

216 huge public health gains, while support for translational research is leading to the development of

217 However, before clinical applications, much translational research is necessary to ensure that their

218 deployment of microfabricated interfaces for translational research is proposed and applied to the so

219 Translational research is supported by RGD's comparative

220 A major limitation in NF2 basic and translational research is the lack of animal models that

221 The term translational research is typically used to refer both t

222 Translational research is usually understood to have evo

223 Further translational research is warranted.

224 ntext of recent progress in metabolomics and translational research methodologies.

225 We aim to provide high impact translational research methodology for cutaneous biology

226 cept of translational physiology applies the translational research model to the physiological scienc

227 nce of combination studies both in basic and translational research necessitates a method that can be

228 multiple hPSC sources and hence addresses a translational research need.

229 In translational research, NINDS is taking the lead on the

230 ein we provide our perspective regarding the translational research objectives of this infection that

231 Recent progress in the translational research of echinocandins has led to new a

232 Translational research of immunohistochemistry protein a

233 in patient risk profiling and for informing translational research of potential gene targets and med

234 vel rat NK cell subset may facilitate future translational research of the role of distinct NK cell s

235 y modified non-human primate can be used for translational research of therapeutics for ASD.

236 To facilitate translational research of these populations, we also pro

237 occurred in the past 5-10 years in clinical translational research of thyroid cancer.

238 cell biologists to venture into the realm of translational research on a regular basis, we would like

239 ions, suggesting behavior change research as translational research on cultural dynamics.

240 o other amygdala nuclei [5], and there is no translational research on its role in experiential learn

241 icle reviews and highlights past and current translational research on SMA therapeutics.

242 In this meeting, translational research on stem cells for disease modelin

243 n between fear and anxiety, before reviewing translational research on the neural circuitry of anxiet

244 iscuss the implications of these results for translational research on the potential use of systemica

245 iewed, along with recommendations for future translational research opportunities.

246 ry burn victims are warranted and serve as a translational research opportunity for uncovering novel

247 ely links areas of research (i.e., basic and translational research, or clinical research and impleme

248 cience results into new interventions-and T2 translational research, or translational research for pu

249 likelihood of funding success: clinical and translational research, outcomes and effectiveness resea

250 e network illustrate the potential impact on translational research, particularly for studies involvi

251 and vestibular rehabilitation from a unified translational research perspective.

252 ht basic concepts, major open questions, and translational research perspectives in cutaneous neuroen

253 e utilized for transplantation, as well as a translational research platform for immunomodulation and

254 nd research should be conducted according to translational research principles in which preclinical r

255 hat we consider particularly promising for a translational research program aimed at furthering our u

256 is an academically based, multidisciplinary, translational research program that for 25 years has sou

257 989); and the Leukemia and Lymphoma Society (Translational Research Program).

258 03532-03), and Leukemia and Lymphoma Society Translational Research Program.

259 d an innovative, cooperative, rapid-response translational-research program that brought together hea

260 specialist clinical services integrated with translational research programmes, but also by joining u

261 We emphasize more recent translational research programs in epigenetics as well a

262 ites, thereby contributing to both basic and translational research programs.

263 -time biopsies are valuable for clinical and translational research purposes, providing insight in ri

264 onducted to focus on the recent clinical and translational research related to the associations betwe

265 isease has been proposed, its application in translational research remains limited.

266 Ongoing translational research seeks to identify the most scient

267 Translational research spanning the past few decades has

268 targeting the immune system may be a viable translational research strategy; preclinical studies hav

269 mparability of results obtained in different translational research studies across laboratories and p

270 Recent basic and translational research studies have significantly improv

271 We review clinical and translational research studies of HF in congenital heart

272 iomarkers and multimodality imaging in early translational research studies.

273 , to the point where we now have 4 stages of translational research (T0-T4).

274 er, these findings support G-CSF as a viable translational research target with the potential to redu

275 erapies represent a culmination of basic and translational research that actually spans many decades.

276 late this knowledge into clinical trials and translational research that can result in public health

277 es is an exciting, rapidly advancing area of translational research that has already entered the clin

278 This review summarizes recent advances in translational research that influence the utility of end

279 ults indicate in a model highly pertinent to translational research that neuronal IGF resistance may

280 te; Johns Hopkins Institute for Clinical and Translational Research; the SAILS trial was also support

281 ment, and it will illustrate how some of the translational research therapies have already entered th

282 nd researchers are an important component of translational research to address obesity.

283 Translational research to develop novel therapeutics aga

284 athology, radiation oncology, radiology, and translational research to develop recommendations for in

285 ncept of atrial failure may foster basic and translational research to gain a better understanding of

286 ence-based practice, and encouraging greater translational research to improve outcome of patients wi

287 te a priority list of genes and pathways for translational research to reduce albuminuria.

288 erspective to stimulate basic, clinical, and translational research to understand how the aging proce

289 ext mining fall both into the category of T1 translational research-translating basic science results

290 These are elegant examples of translational research: understanding basic physiology i

291 The outcome of this translational research unequivocally revealed the cellul

292 s caused by divergent microbiota and limited translational research value.

293 models are poised to realise the promise of translational research via clinical applications such as

294 Translational research was planned to correlate the expr

295 The term 'translational research' was coined 20 years ago and has

296 h PBMC carry many theoretical advantages for translational research, we have found that sample hetero

297 emic surgeons who are pursuing basic science/translational research, which represents a potential thr

298 from ongoing prospective clinical trials and translational research will help clarify whether anesthe

299 have delivered high-impact contributions in translational research, with associated pharmaceutical p

300 Cardiac experimental biology and translational research would benefit from an in vitro su